Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: Results of a matched-pair analysis

Blood

Volumn 97, Issue 10, 2001, Pages 2957-2961

  Barker, Juliet N ^a,b   Davies, Stella M ^a   DeFor, Todd ^a   Ramsay, Norma K C ^a   Weisdorf, Daniel J ^a   Wagner, John E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Box 480   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE;

ADOLESCENT; ARTICLE; BLOOD DISEASE; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CANCER STAGING; CHILD; DONOR; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; INFANT; INTERMETHOD COMPARISON; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; PRIORITY JOURNAL; SURVIVAL RATE; THROMBOCYTE; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

EID: 0035874535     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.2957     Document Type: Article

References (26)

1. Thomas ED, Blume K, Forman S. Hematopoietic Cell Transplantation. 2nd ed. Maiden, MA: Blackwell Science; 1999.
2. Confer DL. Unrelated marrow donor registries. Curr Opin Hematol. 1997;4:408-412.
3. Balduzzi A, Gooley T, Anasetti C, et al. Unrelated donor marrow transplantation in children. Blood. 1995;86:3247-3256.
4. Davies SM, Shu XO, Blazar BR, et al. Unrelated donor bone marrow transplantation: influence of HLAA and B incompatibility on outcome. Blood. 1995;86:1636-1642.
5. Petersdorf EW, Longton GM, Anasetti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood. 1995;86:1606-1613.
6. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilicalcord-blood transplantation in children with malignant and non-malignant disease. Lancet. 1995;346:214-219.
7. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graftversus-host disease. Blood. 1996;88:795-802.
8. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157-166.
9. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373-381.
10. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
11. Wagner JE, DeFor T, Rubinstein P, Kurtzberg J. Transplantation of unrelated donor umbilical cord blood (UCB): outcomes and analysis of risk factors. Blood. 1997;90:398a.
12. MacMillan ML, Auerbach AD, Davies SM, et al. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol. 2000;109:121-129.
13. Wagner JE, Santos GW, Noga SJ, et al. Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. Blood. 1990;75:1370-1377.
14. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley; 1980.
15. Snedecor G, Cochran W. Statistical Methods. 8th ed. Ames, IA: Iowa State University Press; 1989.
16. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
17. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
18. Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 1989;4:247-254.
19. Le C. Applied Survival Analysis. New York, NY: John Wiley; 1997.
20. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood. 1999;93:3662-3671.
21. Laughlin MJ, Barker J, Bambach B, et al. Hematologic engraftment and survival after unrelated placental cord blood transplantation in adult recipients. N Engl J Med. In press.
22. Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342:1846-1854.
23. Surbek DV, Schonfeld B, Tichelli A, Gratwohl A, Holzgreve W. Optimizing cord blood mononuclear cell yield: a randomized comparison of collection before vs after placenta delivery. Bone Marrow Transplant. 1998;22:311-312.
24. Davies SM, Kollman C, Anasetti C, et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program. Blood. 2000;96:4096-4102.
25. Roncarolo MG, Bigler M, Martino S, Ciuti E, Tovo PA, Wagner J. Immune functions of cord blood cells before and after transplantation. J Hematother. 1996;5:157-160.
26. Cohen SB, Dominiguez E, Lowdell M, Madrigal JA. The immunological properties of cord blood: overview of current research presented at the 2nd EUROCORD workshop. Bone Marrow Transplant. 1998;22(suppl 1):S22-25.